MYCN and neuroblastoma: Moreover, AC142119.1 serves as an epigenetic modifier to activate the transcription of MYCN gene by recruiting WDR5 protein to the promoter of MYCN and increasing its H3K4me3 levels, eventually leading to the malignant progression of NB.